Wide Ranks

HQL

TeklaLife Sciences Investors

14.13

Top Statistics
Market Cap 386 M Forward PE 0.0000 Revenue Growth 7.00 %
Current Ratio 0.27 Trailing PE 10.54 Earnings Growth 42.50 %
Profit Margins 156.45 % Peg Ratio Dividend Yield 14.15 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months 110.01
Profitability
Profit Margins 156.45 % Operating Margins -31.63 %
Balance Sheet
Total Cash Total Cash Per Share Total Debt
Total Debt To Equity Current Ratio 0.27 Book Value Per Share 16.13
All Measures
Short Ratio 123.00 % Message Board Id finmb_352795 Shares Short Prior Month 62302
Return On Equity 0.0128 City Philadelphia Uuid d7b9a6c2-6256-3906-a700-e69a97801494
Previous Close 13.92 First Trade Date Epoch Utc 704 M Book Value 16.13
Beta 0.7050 Volume 101292 Price To Book 0.8762
Fifty Two Week Low 11.78 Total Revenue 3 M Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -31.63 %
Last Dividend Value 0.5000 Net Income To Common 5 M Ask 14.10
Implied Shares Outstanding 27 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 115770 Average Volume10days 115770 Next Fiscal Year End 1 B
Revenue Per Share 0.1340 Held Percent Insiders 0.0001 Dividend Rate 2.00
Trailing PE 10.54 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 13.92 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 14.82 Open 14.01 Dividend Yield 14.15 %
State PA Return On Assets -0.0032 Time Zone Short Name EST
Trailing Eps 1.34 Day Low 13.96 Address1 1900 Market Street
Trailing Annual Dividend Rate 1.30 Price Hint 2 Shares Outstanding 27 M
Target High Price 0.0000 52 Week Change 0.1824 Average Volume 74759
Earnings Quarterly Growth 48.70 % Recommendation Key none Forward Eps 0.0000
Compensation As Of Epoch Date 1 B Quick Ratio 0.10 % Is_sp_500 False
Regular Market Day High 14.15 Profit Margins 156.45 % Fifty Two Week High 15.90
Day High 14.15 Shares Short 74117 Regular Market Open 14.01
Industry Key asset-management Bid 14.08 Earnings Growth 42.50 %
Revenue Growth 7.00 % Shares Percent Shares Out 0.0027 Five Year Avg Dividend Yield 926.00 %
Currency USD Market Cap 386 M Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 19103 Payout Ratio 99.25 %
Quote Type EQUITY Industry Asset Management Ex Dividend Date 1 B
Regular Market Day Low 13.96 Held Percent Institutions 0.3535 Long Name Abrdn Life Sciences Investors
Current Price 14.13 Address2 Suite 200 Financial Currency USD
Trailing Annual Dividend Yield 9.34 % Current Ratio 0.27 Gross Margins 100.00 %
Industry Disp Asset Management Country United States Two Hundred Day Average 14.33
Price To Sales Trailing12 Months 110.01 Forward PE 0.0000 Regular Market Volume 101292
Last Dividend Date 1 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.

The fund primarily invests in growth stocks of small cap companies.

It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio.

The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index.

Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.